Peptide and Oligonucleotide CDMO Market Key Players Data, Analysis by Size, Share, Opportunities, Revenue, Future Scope and Forecast 2029
The global Peptide and Oligonucleotide CDMO market reached a value of USD 1.7 billion in 2022 and is expected to experience a steady rise in the coming years. Analysts predict a Compound Annual Growth Rate (CAGR) of 10.7% for the market between 2023 and 2029. Peptide and Oligonucleotide CDMO Market Overviews In the ever-shifting world of economics, staying abreast...
0 Comments 0 Shares 6419 Views